| (210) | Number of the EPO application | 17828540 |
| (220) | Filing date of the EPO application | 2017.07.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 17/2021, 2021.04.28 |
| (110) | EPO patent number | 3496739 |
| (11) | Number of the document | MD 3496739 T2 |
| (21) | Number of the application | e 2019 0695 |
| (71) | Name(s) of applicant(s), code of the country | ACCELERON PHARMA INC., US; |
| (72) | Name(s) of inventor(s), code of the country | KUMAR Ravindra, US;
KNOPF John, US; |
| (73) | Name(s) of owner(s), code of the country | ACCELERON PHARMA INC., US; |
| (54) | Title of the invention | Compositions comprising ActRIIA polypeptides for use in treating pulmonary hypertension |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 38/17 (2006.01.01); A61K 47/68 (2017.01.01); A61P 7/00 (2006.01.01); A61P 11/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.07.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.09.30 |
| (30) | Priority | 201662362955 P, 2016.07.15, US; 201762453888 P, 2017.02.02, US; 201762510403 P, 2017.05.24, US |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2017/042157, 2017.07.14 |
| (87) | International publication | WO 2018/013936, 2018.01.18 |